Standard Antibiotic Treatment Fails Many Enteric Fever Cases

For patients with enteric fever, standard antibiotics like ciprofloxacin are increasingly ineffective, necessitating new care plans.

Updated on Oct. 28, 2026 in Diseases — General

Stack of glass petri dishes containing bacterial cultures on a clean laboratory surface. — CDC researchers report that Salmonella Typhi and Paratyphi bacteria increasingly show low susceptibility to ciprofloxacin, challenging standard enteric fever treatment protocols in the U.S. AI Illustration. Upload story photo >

Live Poll

Should doctors prioritize updated antibiotic resistance data when determining standard treatment protocols?

CDC researchers found that most Salmonella Typhi and Paratyphi isolates in the United States from 2016 to 2020 show low susceptibility to ciprofloxacin. This rise in antibiotic resistance, largely linked to recent international travel, indicates that standard treatment protocols may require adjustment.

Why it matters

The high prevalence of non-susceptible strains suggests that fluoroquinolones like ciprofloxacin are increasingly ineffective for empiric treatment of enteric fever. This shift requires clinicians to reconsider traditional antibiotic choices for patients returning from endemic regions.

This retrospective analysis of 2,342 enteric fever cases identified through national surveillance systems from 2016 to 2020 found that the vast majority of isolates were not susceptible to ciprofloxacin. While ceftriaxone resistance was lower at 5.5%, the high rate of fluoroquinolone non-susceptibility highlights a significant challenge for current treatment strategies.

The players

CDC

The United States public health agency responsible for disease monitoring and infection control guidance.

The details

Enteric fever is caused by Salmonella Typhi and Paratyphi bacteria, which often spread through contaminated food or water. Ciprofloxacin was established as a first-line treatment in the 1980s, but global antibiotic resistance is changing how these bacteria respond to therapy. When bacteria are non-susceptible, the antibiotic fails to adequately inhibit growth, necessitating the use of alternative, often more specialized, antimicrobial agents to clear the infection.

• Ciprofloxacin became a first-line enteric fever treatment in the 1980s.
• An extensively drug-resistant Salmonella strain emerged in Pakistan in 2016.
• The study analyzed U.S. case data collected between 2016 and 2020.
• Research findings were published in October 2026.

Health Landscape

The global rise of drug-resistant pathogens has fundamentally altered the management of enteric fever, moving away from reliance on older, first-line antibiotics. This study reflects the broader trend of international disease transmission and the urgent need for updated clinical standards in antibiotic stewardship.

If you are planning international travel to areas where enteric fever is common, discuss preventive vaccination and updated treatment strategies with a travel medicine specialist. Patients who develop high fevers after returning from abroad should inform their physician about their travel history to ensure appropriate diagnostic testing and antibiotic selection.

The takeaway

Antibiotic resistance has significantly reduced the efficacy of traditional treatments for enteric fever. If you have recently traveled internationally, monitor for persistent fever and consult your doctor to ensure that any potential infection is treated with antibiotics that remain effective against current resistant strains.